Vise Technologies’s Quest Diagnostics DGX Stock Holding History

Vise Technologies’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$765K	Sell	3,611 -197	-5%	-$38.7K	0.01%	935
2026 Q1	$661K	Hold	3,808	–	–	0.01%	745
2025 Q4	$661K	Buy	3,808 +1,855	+95%	+$338K	0.01%	750
2025 Q3	$372K	Sell	1,953 -1,453	-43%	-$258K	0.01%	804
2025 Q2	$612K	Buy	+3,406	New	+$592K	0.03%	570

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Vise Technologies's DGX Position: Q2 2026 in Review

Vise Technologies reduced its Quest Diagnostics (DGX) stake by 5.2% in Q2 2026, selling an estimated $38.7K and leaving 3,611 shares worth $765K. The position accounts for 0.01% of the portfolio, ranked #935.

Vise Technologies first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Vise Technologies held 3,611 shares of Quest Diagnostics worth $765K as of Q2 2026.
Vise Technologies sold 197 Quest Diagnostics shares in Q2 2026, an estimated $38.7K.
Quest Diagnostics made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #935 holding.
Vise Technologies first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.